- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.01. | Pfizer, PhRMA rank among groups pledging funding for Trump's inauguration: NYT | ||
| 06.01. | In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics | ||
| 06.01. | Citius Oncology weighs strategic options on road to launching newly-approved lymphoma med | ||
| 06.01. | 'Ozempic's biggest night': GLP-1s back in Hollywood spotlight at Lilly-backed 2025 Golden Globes | ||
| 06.01. | Amylyx names chief commercial officer as GLP-1 receptor antagonist launch plans start ramping up | ||
| 03.01. | Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row | ||
| 03.01. | Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate | ||
| 03.01. | BioNTech inks settlements with NIH, Penn in COVID-19 vaccine royalty disputes | ||
| 03.01. | CRO Veeda unveils 'modern and dynamic' rebrand to mirror expansion into CDMO services | ||
| 03.01. | Astellas, Endo issue US drug recalls over empty capsule, ingredient concerns | ||
| 03.01. | Study sparks call for funding reforms to protect patient groups from pharma influence | ||
| 02.01. | Regulatory tracker: Amgen's bispecific approved for small cell lung cancer in UK | ||
| 02.01. | Digital Health Trends 2024: Implications for Research and Patient Care | ||
| 02.01. | Fierce Pharma Asia-Roche, Innovent's ADC deal; Lessons from AstraZeneca's China probes; Viatris' warning letter | ||
| 02.01. | Lilly looks to 'protect its interests' by moving to join FDA lawsuit over compounded tirzepatide | ||
| 02.01. | Currax's first Contrave TV ad claims 'Cravings Don't Own Me' complete with classic song parody | ||
| 02.01. | After delay with FDA, Novartis touts pivotal trial win for intrathecal Zolgensma in older SMA patients | ||
| 02.01. | After phase 3 setbacks, troubled Marinus inks $151M sale to Immedica Pharma | ||
| 02.01. | With $608M divestment, Hutchmed continues to focus on ADC development | ||
| 02.01. | Pfizer, BMS and more ring in 2025 with fresh round of drug price increases: report | ||
| 02.01. | Lilly's Zepbound expected to surpass Novo's Wegovy to 'dominate' obesity market: GlobalData | ||
| 02.01. | Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version | ||
| 19.12.24 | Sanofi and Regeneron's Dupixent, Leo Pharma's Anzupgo could help close treatment gap in chronic hand eczema: GlobalData | ||
| 19.12.24 | FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs | ||
| 19.12.24 | Klick Health goes on a hiring spree to close out the year, adding 22 new leaders |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
